.svg)
Albendazole 400 Mg
Price range: $24.00 through $60.00
Albendazole 400 Mg is a broad-spectrum antiparasitic medication commonly used in human medicine to treat infections caused by intestinal worms and other helminths. It belongs to the benzimidazole class of drugs and works by inhibiting the parasite’s ability to absorb glucose, leading to energy depletion and eventual parasite death. Albendazole is widely prescribed for conditions such as roundworm, hookworm, pinworm infections, neurocysticercosis, and hydatid disease caused by tapeworm larvae.
Beyond its established role in treating parasitic infections, Albendazole has also gained attention in scientific research exploring drug repurposing in oncology. Preclinical studies suggest that Albendazole may interfere with microtubule formation in rapidly dividing cells, which could potentially inhibit tumor growth and trigger apoptosis in certain cancer cell lines. However, these findings remain investigational, and Albendazole is not currently approved as a standard cancer treatment.
For medical safety, Albendazole should always be used under the supervision of a qualified healthcare professional, especially in long-term therapies where monitoring of liver function may be recommended.
Description
Albendazole 400 Mg – Research-Supported Antiparasitic with Investigational Oncology Potential
Albendazole 400 mg is a widely used anthelmintic medication belonging to the benzimidazole class of drugs. It is primarily prescribed to treat parasitic infections in humans such as tapeworm infections, hydatid disease, neurocysticercosis, and intestinal helminth infections. The drug works by interfering with the parasite’s microtubule formation, preventing nutrient absorption and leading to parasite death.
In recent years, Albendazole has also attracted scientific interest as a repurposed drug candidate in oncology research. Several preclinical studies have explored its ability to inhibit tumor cell growth, disrupt cancer cell division, and trigger apoptosis (programmed cell death) in certain cancer cell lines.
While Albendazole remains an approved antiparasitic medicine, its potential role in cancer treatment is currently investigational and studied in laboratory and preclinical settings. Patients should only use the medication under the supervision of a licensed medical professional.
Comprehensive parasite-management strategies may also incorporate Fenbendazole 150 Mg Tablets as part of broader investigational antiparasitic therapy approaches.
Mechanism of Action
Albendazole acts by targeting beta-tubulin proteins inside parasitic cells, preventing microtubule polymerization. This disrupts glucose uptake and energy metabolism, eventually causing parasite death.
Researchers have observed that similar microtubule-disrupting mechanisms may also influence cancer cell proliferation. Experimental studies show that Albendazole may:
Interfere with tumor cell division
Induce apoptosis pathways in malignant cells
Reduce colony formation and invasive growth in certain cancer models
Affect signaling pathways such as Wnt/β-catenin involved in tumor progression
These mechanisms are currently being evaluated in preclinical oncology research to understand whether repurposed antiparasitic drugs could support future cancer treatment strategies.
Albendazole and Cancer Research
Scientists are increasingly investigating drug repurposing in oncology, where approved medicines are studied for new therapeutic uses. Albendazole has shown promising effects in several laboratory studies:
Colon cancer cell growth inhibition
Pancreatic cancer cell proliferation suppression
Activation of apoptosis pathways in tumor cells
Enhancement of immune response by modulating PD-L1 pathways
For example, research published in oncology journals reported that Albendazole can reduce tumor cell survival and induce apoptosis in colon cancer cell lines.
Another study demonstrated suppression of pancreatic cancer cell proliferation and migration after Albendazole treatment in laboratory models.
These findings suggest potential therapeutic value, although well-controlled clinical trials in humans are still needed before Albendazole could be considered part of standard oncology treatment.
Medical Uses of Albendazole 400 Mg
Clinically, Albendazole is approved for treating various parasitic infections in humans, including:
Neurocysticercosis caused by pork tapeworm larvae
Hydatid disease caused by Echinococcus species
Ascariasis
Hookworm infections
Pinworm infections
Strongyloidiasis
Cutaneous larva migrans
The medication is typically administered orally and may be taken with food, especially fatty meals, to enhance absorption.
Safety, Dosage, and Clinical Considerations
Albendazole should always be used according to medical guidance. Dosage depends on the specific infection, patient age, weight, and clinical condition.
Possible side effects include:
Abdominal pain
Headache
Nausea
Elevated liver enzymes
Rare bone marrow suppression during prolonged use
Because long-term therapy may affect liver function, healthcare providers often recommend periodic liver function tests during treatment.
Patients who are pregnant, breastfeeding, or taking other medications should consult a physician before using Albendazole.
Comprehensive parasite-elimination protocols may include Anti Parasitic Kit – 2 Months within structured detoxification and parasite-management programs.
Medical Disclaimer
Albendazole is FDA-approved and globally recognized for treating parasitic infections. The discussion of cancer-related mechanisms on this page refers to scientific research and experimental studies only.
Albendazole is not currently approved as a standard cancer treatment, and individuals should never self-medicate for cancer without professional medical supervision.
High-Authority Medical References
For evidence-based medical information about Albendazole and its investigational role in oncology, refer to the following authoritative sources:
NCBI Medical Reference:
Anchor Text: Albendazole clinical pharmacology overviewPeer-Reviewed Oncology Review:
Anchor Text: Albendazole and Mebendazole as Anti-Cancer Agents
These references provide detailed information on Albendazole’s pharmacology, safety profile, and emerging research in cancer biology.
FAQs
Albendazole 400 mg is primarily prescribed to treat parasitic infections caused by worms and other helminths. It belongs to the benzimidazole class of medications and works by disrupting the internal cellular structure of parasites. This prevents them from absorbing glucose and other nutrients, eventually leading to their death. Physicians commonly prescribe Albendazole for conditions such as neurocysticercosis, hydatid disease, and intestinal worm infections including roundworm, hookworm, and pinworm infestations.
The medication is typically taken orally and may be used in single-dose or multi-day treatment regimens depending on the infection being treated. In some severe parasitic diseases, treatment may continue for several weeks under strict medical monitoring. Albendazole is widely used worldwide due to its broad spectrum of activity and generally favorable safety profile when used appropriately.
Albendazole is not currently approved as a cancer treatment, but it has been studied extensively in laboratory and preclinical research for potential anti-cancer effects. Researchers have observed that Albendazole may interfere with microtubule formation in cells, which is an important process required for cell division. Since cancer cells divide rapidly, drugs that disrupt microtubules can sometimes slow or stop tumor growth.
Several studies have shown that Albendazole can inhibit cancer cell proliferation and induce apoptosis in certain tumor cell lines, including colon and pancreatic cancer cells. However, these findings mainly come from laboratory experiments and animal studies. More clinical trials involving human patients are needed before Albendazole could be recommended for oncology treatment.
Experimental oncology research has shown that Albendazole may influence cancer cells through several biological mechanisms. One of the most important mechanisms is microtubule disruption, which prevents cancer cells from successfully completing cell division. When this process is interrupted, the cells may enter a state of cell cycle arrest and eventually undergo apoptosis, or programmed cell death.
Researchers have also observed that Albendazole can affect signaling pathways involved in tumor progression. These include pathways related to apoptosis, immune system activation, and cancer stem cell regulation. In some experimental models, Albendazole reduced tumor growth and decreased the ability of cancer cells to migrate or invade surrounding tissue. Although these results are promising, they are still considered preliminary and require further clinical investigation.
Albendazole is generally considered safe when used for short treatment courses to manage parasitic infections. However, long-term use may increase the risk of certain side effects and therefore requires medical supervision. When treatment continues for extended periods, healthcare providers may monitor liver function and blood cell counts to ensure patient safety.
Some patients may experience mild side effects such as nausea, headache, dizziness, or abdominal discomfort. In rare cases, prolonged therapy can lead to liver enzyme elevation or bone marrow suppression. Because of these potential risks, Albendazole should always be taken under the guidance of a qualified healthcare professional who can evaluate the appropriate dosage and duration of treatment.
Albendazole tablets are usually taken orally, either as a single dose or as part of a multi-day treatment regimen depending on the infection being treated. Many healthcare providers recommend taking the medication with food, particularly fatty meals, because this can improve absorption and increase the drug’s effectiveness.
The exact dosage and treatment schedule will depend on factors such as the type of parasitic infection, the patient’s age, body weight, and overall health status. For example, infections such as pinworm may require only a single dose, while conditions like hydatid disease may require longer treatment cycles. Patients should carefully follow their doctor’s instructions and complete the full course of treatment to ensure effective parasite elimination.
RELATED PRODUCTS
Artesunate 120 mg Injection
Fenbendazole 444 Mg Tablets
Fenbendazole Cream
Fenbendazole Tablets 1000 Mg
Iverheal 12 mg – Ivermectin
Iverheal 6 Mg – Ivermectin
Ivrea – Ivermectin Cream 1%
Reviews
There are no reviews yet.